0001104659-22-002361.txt : 20220107
0001104659-22-002361.hdr.sgml : 20220107
20220107181153
ACCESSION NUMBER: 0001104659-22-002361
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220104
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Power Sean A
CENTRAL INDEX KEY: 0001538845
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 22519198
MAIL ADDRESS:
STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
tm222217d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-04
0
0001001316
TG THERAPEUTICS, INC.
TGTX
0001538845
Power Sean A
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
0
1
0
0
CFO, Secretary and Treasurer
COMMON STOCK
2022-01-04
4
S
0
75312
19.20
D
578136
D
COMMON STOCK
2022-01-05
4
S
0
9653
18.31
D
568483
D
In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing.
/s/ Sean A Power
2022-01-05